Teva Pharmaceutical CEO on Bringing His Company Back from the Brink | Barron's
Teva CEO Vigodman Steps Down After Poor Outlook for 2017 | Fortune
Teva mulling bid for Mylan – Bloomberg - Globes
teva: Teva shows the flip side of rapidly growing corporate leverage - The Economic Times
Teva Pharmaceutical Industries Stock Is Believed To Be Modestly Undervalued
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva to pay $85m to Oklahoma over opioid case | Financial Times
Is Teva Pharmaceutical (TEVA) a Good Stock to Pick Now?
Teva Copaxone Sales: Teva Falls As Sales Of Copaxone Decline Faster Than Expected
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva Has No Plans for Covid Vaccine Research, CEO Kare Schultz Says: Video - Bloomberg
Teva Stock Climbs as Earnings Hint at Turnaround | Barron's
Teva's New CEO Schultz Says Forget About Recovery This Year
Five Considerations After Teva Pharmaceuticals' Q3 Report (NYSE:TEVA) | Seeking Alpha
Teva's Budding Blockbusters Lend Respite From Legal Concerns
テバ：株価急落－４～６月は18％減収、北米ジェネリック販売低迷 - Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - BNN Bloomberg
テバ：株価急落－４～６月は18％減収、北米ジェネリック販売低迷 - Bloomberg
Glaxo's Win in Case Against Teva Lifts Other Drugmakers - Bloomberg
Israel's Teva in talks to set up China venture with Guangzhou Pharma
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Teva Analysts Say Migraine Drug Approval Gives Needed Relief
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
